These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019. Lin W; Xie Z; Li Y; Li L; Wen C; Cao Y; Chen X; Ou X; Hu F; Li F; Tang X; Cai W; Li L J Med Virol; 2021 Feb; 93(2):794-802. PubMed ID: 32672840 [TBL] [Abstract][Full Text] [Related]
9. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19. Liu Y; Liao W; Wan L; Xiang T; Zhang W Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic. El Zein S; Chehab O; Kanj A; Akrawe S; Alkassis S; Mishra T; Shatta M; El-Hor N; Salimnia H; Chandrasekar P PLoS One; 2021; 16(9):e0255981. PubMed ID: 34529675 [TBL] [Abstract][Full Text] [Related]
11. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19. Carmo A; Pereira-Vaz J; Mota V; Mendes A; Morais C; da Silva AC; Camilo E; Pinto CS; Cunha E; Pereira J; Coucelo M; Martinho P; Correia L; Marques G; Araújo L; Rodrigues F J Med Virol; 2020 Oct; 92(10):2227-2231. PubMed ID: 32484958 [TBL] [Abstract][Full Text] [Related]
12. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada. Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740 [TBL] [Abstract][Full Text] [Related]
13. Viral load dynamics in intubated patients with COVID-19 admitted to the intensive care unit. Boef AGC; van Wezel EM; Gard L; Netkova K; Lokate M; van der Voort PHJ; Niesters HGM; Van Leer Buter C J Crit Care; 2021 Aug; 64():219-225. PubMed ID: 34023553 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome. Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A Viruses; 2021 Feb; 13(2):. PubMed ID: 33670360 [TBL] [Abstract][Full Text] [Related]
16. Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death. Mancini N; Clementi N; Ferrarese R; Ambrosi A; Tonelli M; Zangrillo A; Landoni G; Clementi M Clin Chem Lab Med; 2021 May; 59(6):e247-e250. PubMed ID: 33577724 [No Abstract] [Full Text] [Related]
17. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Ziegler CGK; Miao VN; Owings AH; Navia AW; Tang Y; Bromley JD; Lotfy P; Sloan M; Laird H; Williams HB; George M; Drake RS; Christian T; Parker A; Sindel CB; Burger MW; Pride Y; Hasan M; Abraham GE; Senitko M; Robinson TO; Shalek AK; Glover SC; Horwitz BH; Ordovas-Montanes J Cell; 2021 Sep; 184(18):4713-4733.e22. PubMed ID: 34352228 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children. Kam KQ; Thoon KC; Maiwald M; Chong CY; Soong HY; Loo LH; Tan NWH; Li J; Nadua KD; Yung CF Epidemiol Infect; 2021 Jan; 149():e18. PubMed ID: 33427152 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19. Kawasuji H; Morinaga Y; Tani H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Kimura M; Yamada H; Sakamaki I; Yamamoto Y J Med Virol; 2022 Jan; 94(1):147-153. PubMed ID: 34411312 [TBL] [Abstract][Full Text] [Related]
20. A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia. Pita-Martínez C; Pérez-García F; Virseda Berdices A; Martin-Vicente M; Castilla-García L; Hervás Fernández I; González Ventosa V; Muñoz-Gómez MJ; Cuadros-González J; Bermejo-Martin JF; Resino S; Martínez I Int J Infect Dis; 2023 Sep; 134():126-132. PubMed ID: 37290572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]